Faron Pharmaceuticals Oy (AIM:FARN)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 30.95
-0.05 (-0.16%)
Nov 4, 2026, 4:23 PM GMT
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 63.92 million as of November 4, 2026. It is the 26,138th most valuable company in the world and the 586th biggest in the United Kingdom. Its market cap has decreased by 72.62% in one year.
Market Cap
63.92M
Enterprise Value
51.82M
Revenue
n/a
Global Rank
Country Rank
#586 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 53.46M to 63.92M, an increase of 19.57%. That is a compound annual growth rate of 1.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 63.92M | -68.96% |
| Dec 31, 2025 | 205.96M | -3.97% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 285.74M |
| Bioventix | 107.06M |
| Scancell Holdings | 104.46M |
| 4basebio | 81.62M |
| Ondine Biomedical | 52.19M |
| Poolbeg Pharma | 48.10M |
| Hemogenyx Pharmaceuticals | 41.07M |
| Arecor Therapeutics | 38.51M |